Seres Therapeutics

Finch Therapeutics Fetches $90M to Advance Microbiome Drug Pipeline
Finch Therapeutics Fetches $90M to Advance Microbiome Drug Pipeline
Xconomy
microbiome
Finch Therapeutics
Seres Therapeutics
Flag link:
Battered and bruised Seres Therapeutics see shares skyrocket on phase 3 win
Battered and bruised Seres Therapeutics see shares skyrocket on phase 3 win
Fierce Biotech
Seres Therapeutics
SER-109
C. difficile
microbiome
Flag link:
Seres Therapeutics stock rockets nearly fourfold after positive Phase 3 data on treatment for colon infections
Seres Therapeutics stock rockets nearly fourfold after positive Phase 3 data on treatment for colon infections
Marketwatch
Seres Therapeutics
microbiome
clinical trials
SER-109
Flag link:
Microbiome Report for Week Ending 6/22/19
Microbiome Report for Week Ending 6/22/19
CP Wire
microbiome
Axial Biotherapeutics
EnteroBiotix
Seres Therapeutics
Synlogic
Ginkgo Bioworks
Flag link:
Microbiome Report for Week Ending 6/22/19
microbiome
Axial Biotherapeutics
EnteroBiotix
Seres Therapeutics
Synlogic
Ginkgo Bioworks
Flag link:
Microbiome-Focused Seres Therapeutics Inc. Announces Proposed Common Stock Offering
Microbiome-Focused Seres Therapeutics Inc. Announces Proposed Common Stock Offering
CP Wire
Seres Therapeutics
C. difficile
ulcerative colitis
Flag link:
Microbiome-Focused Seres Therapeutics Inc. Announces Proposed Common Stock Offering
Seres Therapeutics
C. difficile
ulcerative colitis
Flag link:
Microbiome Report for Week Ending 4/6/19
Microbiome Report for Week Ending 4/6/19
CP Wire
C3J Therapeutics
bacteriophage
Enterome
Seres Therapeutics
SER-401
Flag link:
Microbiome Report for Week Ending 4/6/19
C3J Therapeutics
bacteriophage
Enterome
Seres Therapeutics
SER-401
Flag link:
Microbiome Report for Week Ending 3/16/19
Microbiome Report for Week Ending 3/16/19
CP Wire
microbiome
Seres Therapeutics
AstraZeneca
stroke
Flag link:
Microbiome Report for Week Ending 3/16/19
microbiome
Seres Therapeutics
AstraZeneca
stroke
Flag link:
AstraZeneca lines up a $20M installment plan to launch a new oncology collaboration with microbiome player Seres
AstraZeneca lines up a $20M installment plan to launch a new oncology collaboration with microbiome player Seres
Endpoints
AstraZeneca
oncology
microbiome
Seres Therapeutics
Flag link:
Microbiome Report for Week Ending 2/9/19
Microbiome Report for Week Ending 2/9/19
CP Wire
microbiome
Seres Therapeutics
Kallyope
Flag link:
Microbiome Report for Week Ending 2/9/19
microbiome
Seres Therapeutics
Kallyope
Flag link:
New CEO axes 30% of Seres’ workforce to refocus on ‘high priority’ late-stage efforts
New CEO axes 30% of Seres’ workforce to refocus on ‘high priority’ late-stage efforts
Fierce Biotech
Seres Therapeutics
layoffs
Flag link:
Microbiome Report for Week Ending 1/19/19
Microbiome Report for Week Ending 1/19/19
CP Wire
microbiome
Seres Therapeutics
Synlogic
Kaleido Biosciences
IPOs
Flag link:
Microbiome Report for Week Ending 1/19/19
microbiome
Seres Therapeutics
Synlogic
Kaleido Biosciences
Flag link:
Seres Therapeutics Appoints Industry Veteran as Chief Medical Officer
Seres Therapeutics Appoints Industry Veteran as Chief Medical Officer
CP Wire
Seres Therapeutics
microbiome
Flag link:
Seres Therapeutics Appoints Industry Veteran as Chief Medical Officer
Seres Therapeutics
Flag link:
Microbiome Report for Week Ending 10/6/18
Microbiome Report for Week Ending 10/6/18
CP Wire
Rebiotix
Vedanta Biosciences
Seres Therapeutics
LNC Therapeutics
Synlogic
Flag link:

Pages